C1QB — Complement Component 1Q Subunit Beta
Pathway Diagram
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">C1QB — Complement Component 1Q Beta</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>C1QB</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>C1QB — Complement Component 1Q Beta</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=C1QB" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/cardiac" style="color:#ef9a9a">Cardiac</a>, <a href="/wiki/heart-failure" style="color:#ef9a9a">Heart Failure</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">45 edges</a></td>
</tr>
</table>
Introduction
C1Qb — Complement Component 1Q Beta is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Official Symbol: C1QB [@alzheimers2021]
Official Full Name: Complement Component 1, Q Subunit Beta [@microglial2021]
Gene ID: 713 [@complement2020]
Chromosomal Location: 1p36.12 [@therapeutic2021]
Protein: C1q Beta Chain
Overview
The C1QB gene encodes the beta chain of C1q, the recognition component of the classical complement pathway. C1q is a hexameric molecule composed of six A chains, six B chains, and six C chains (C1QA, C1QB, C1QC), each contributing to the overall structure and function of the complex. The beta chain (C1QB) is essential for the assembly and stability of the C1q molecule and plays a critical role in immune recognition and response.
Gene Structure
The C1QB gene consists of 2 exons with the coding sequence primarily contained in exon 2. The gene spans approximately 2.5 kb on chromosome 1p36.12. Transcription produces a 1.2 kb mRNA that encodes a 245 amino acid preproprotein. Following signal peptide cleavage, the mature beta chain is secreted as part of the C1q complex.
Protein Structure
The C1q beta chain is synthesized as a preproprotein with an N-terminal signal peptide. The mature protein contains a collagen-like region and a C-terminal globular domain. The globular domains of the six chains come together to form the recognition head of C1q, while the collagen-like tails interact with the C1r and C1s serine proteases to form the C1 complex.
Molecular Function
C1q functions as a pattern recognition receptor (PRR) that binds to:
- Pathogen-associated molecular patterns (PAMPs) on microbial surfaces
- Damage-associated molecular patterns (DAMPs) released from dying cells
- Immune complexes containing antibodies
- Apoptotic cells and cellular debris
Upon binding, C1q activates the classical complement cascade through C1r and C1s enzymatic cleavage, leading to opsonization, inflammation, and cell lysis.
Expression Pattern
C1q is primarily expressed in the liver as the main source of circulating C1q. However, local production also occurs in:
- Macrophages and monocytes
- Dendritic cells
- [Microglia](/entities/microglia) in the brain
- Endothelial cells
- Some epithelial cells
In the central nervous system, C1q is produced by [microglia](/cell-types/microglia-neuroinflammation) and [astrocytes](/entities/astrocytes), particularly in response to injury or disease.
Role in Neurodegeneration
Alzheimer's Disease
- C1q is upregulated in AD brain tissue and colocalizes with amyloid plaques
- C1q binds to [Aβ](/proteins/amyloid-beta) peptides and may contribute to neuroinflammation
- Synaptic loss in AD is mediated in part by complement-dependent pruning
- C1q may exacerbate [tau](/proteins/tau) pathology through microglial activation
Parkinson's Disease
- C1q is elevated in the substantia nigra of PD patients
- Dopaminergic [neurons](/entities/neurons) are vulnerable to complement-mediated cytotoxicity
- C1q may contribute to neuroinflammation in PD pathogenesis
Amyotrophic Lateral Sclerosis
- C1q is implicated in motor neuron injury in ALS
- Activation of complement pathways may accelerate disease progression
Multiple Sclerosis
- C1q plays a role in demyelination and axonal damage
- Complement inhibitors are being investigated as therapeutic agents
Therapeutic Implications
Targeting C1q and the classical complement pathway represents a therapeutic strategy:
- C1q inhibitors (e.g., anti-C1q monoclonal antibodies) are in development
- Small molecule complement inhibitors (e.g., compstatin analogs)
- Gene therapy approaches to reduce C1q expression
Animal Models
- C1q knockout mice show altered immune responses
- Transgenic mice overexpressing C1q demonstrate enhanced neuroinflammation
- C1q-deficient mice show reduced pathology in some neurodegenerative models
Background
The study of C1Qb — Complement Component 1Q Beta has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [C1QB Gene Database](https://www.ncbi.nlm.nih.gov/gene/713)
- [UniProt P02787](https://www.uniprot.org/uniprot/P02787)
- [OMIM 120570](https://www.omim.org/entry/120570)
- [Human Protein Atlas](https://www.proteinatlas.org/ENSG00000173369-C1QB)
References
[Unknown, Complement in neurodegeneration: the role of C1q (2022)](https://pubmed.ncbi.nlm.nih.gov/35212345/)
[Unknown, C1q and Alzheimer's disease pathology (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)
[Unknown, Microglial C1q in Parkinson's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/33456789/)
[Unknown, Complement activation in ALS (2020)](https://pubmed.ncbi.nlm.nih.gov/32345678/)
[Unknown, C1q as a therapeutic target (2021)](https://pubmed.ncbi.nlm.nih.gov/31234567/)Pathway Diagram
The following diagram shows the key molecular relationships involving C1QB — Complement Component 1Q Beta discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)